Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia
Clinical trial NCT04263480 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04263480
- Sponsor
- Christian Buske
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2028-05-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.